Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05139368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer

Name: Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer — clinical trial record (NCT05139368)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RT-PACE

StatusActive, Not Recruiting

PhaseNot applicable

SponsorUniversity of Utah

Started2021-11-11

View on ClinicalTrials.gov ↗

This clinical trial studies the feasibility of using hypo-fractionated radiotherapy for the treatment of cervical or endometrial cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.

Amendment history 2 changes detected by DataLookout

2026-09-05

Primary endpoint(s) modified

Was~~Ability to administer clinical trial to evaluate hypofractionated radiotherapy,~~ Change in ~~toxicity~~

NowChange in Toxicity - Bowel Summary Score, Trial Feasibility - Number of Evaluable Patients

2026-09-05

Results posted: 2026-09-04

Trial Details

NCT Number	NCT05139368
Lead Sponsor	University of Utah Collaborators: National Cancer Institute (NCI)
Conditions	Cervical Carcinoma, Endometrial Carcinoma
Enrollment	22 participants
Start Date	2021-11-11
Primary Completion	2024-07-17 (estimated)
Study Completion	2027-06-26 (estimated)
Updated on ClinicalTrials.gov	2026-09-04